BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 21/07/2023

Prospective Grant of an Exclusive Patent License: Development and Commercialization of Caspase Inhibitors

The National Center for Advancing Translational Sciences is contemplating the grant of an Exclusive Patent License to Elgia Therapeutics Inc. for the development and commercialization of caspase inhibitors.

Source: Federal Register — Health and Human ServicesOpen original release →